Literature DB >> 25609579

[Modern imaging of liver metastases].

J Breitenseher1, M Pones, G Wengert, A Ba-Ssalamah.   

Abstract

CLINICAL/METHODICAL ISSUE: The liver is the second most common location of metastases following the lymph nodes. The accurate characterization of focal liver lesions in oncology patients is especially important because of the high prevalence of benign liver lesions and the possibility of co-existing benign and malignant lesions. The exact interpretation of these lesions is crucial for therapeutic decisions and thus for the prognosis of the patient. STANDARD RADIOLOGICAL
METHODS: It is essential to detect all focal liver lesions and to distinguish benign from malignant lesions, especially in the management of oncology patients. Numerous imaging modalities are available for these challenges in the daily routine. An extensive understanding of the advantages and limitations of the various imaging modalities and knowledge of the morphology and the typical and atypical appearances of the different metastases is important. METHODICAL INNOVATIONS: This review explains the radiological criteria for various metastases in different modalities. To evaluate the individual prognosis and risk assessment preoperatively, functional imaging is necessary. These personalized pretherapeutic diagnostics are discussed.

Entities:  

Mesh:

Year:  2015        PMID: 25609579     DOI: 10.1007/s00117-014-2706-7

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  26 in total

Review 1.  Liver metastases.

Authors:  W Schima; C Koelblinger; G Lesnik; A Ba-Ssalamah
Journal:  JBR-BTR       Date:  2011 Jul-Aug

Review 2.  The Rocky liver: radiologic-pathologic correlation of calcified hepatic masses.

Authors:  C Stoupis; H M Taylor; M R Paley; P C Buetow; S Marre; H U Baer; P Vock; P R Ros
Journal:  Radiographics       Date:  1998 May-Jun       Impact factor: 5.333

3.  Preoperative detection of colorectal liver metastases in fatty liver: MDCT or MRI?

Authors:  Vanessa Kulemann; Wolfgang Schima; Dietmar Tamandl; Klaus Kaczirek; Thomas Gruenberger; Friedrich Wrba; Michael Weber; Ahmed Ba-Ssalamah
Journal:  Eur J Radiol       Date:  2010-04-13       Impact factor: 3.528

Review 4.  Liver metastases: Contrast-enhanced ultrasound compared with computed tomography and magnetic resonance.

Authors:  Vito Cantisani; Hektor Grazhdani; Cristina Fioravanti; Maria Rosignuolo; Fabrizio Calliada; Daniela Messineo; Maria Giulia Bernieri; Adriano Redler; Carlo Catalano; Ferdinando D'Ambrosio
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

Review 5.  [Improvement in diagnosis of liver metastases with the multi-detector CT].

Authors:  C Kulinna; T Helmberger; M Kessler; M Reiser
Journal:  Radiologe       Date:  2001-01       Impact factor: 0.635

6.  68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT.

Authors:  Michael Gabriel; Clemens Decristoforo; Dorota Kendler; Georg Dobrozemsky; Dirk Heute; Christian Uprimny; Peter Kovacs; Elisabeth Von Guggenberg; Reto Bale; Irene J Virgolini
Journal:  J Nucl Med       Date:  2007-04       Impact factor: 10.057

7.  Cystic focal liver lesions in the adult: differential CT and MR imaging features.

Authors:  K J Mortelé; P R Ros
Journal:  Radiographics       Date:  2001 Jul-Aug       Impact factor: 5.333

8.  Spectrum of MRI appearances of untreated metastases of the liver.

Authors:  Ioana-Maria Danet; Richard C Semelka; Polytimi Leonardou; Larissa Braga; Georgeta Vaidean; John T Woosley; Masayuki Kanematsu
Journal:  AJR Am J Roentgenol       Date:  2003-09       Impact factor: 3.959

9.  Liver failure after major liver resection: risk assessment by using preoperative Gadoxetic acid-enhanced 3-T MR imaging.

Authors:  Andreas Wibmer; Alexander M Prusa; Richard Nolz; Thomas Gruenberger; Martin Schindl; Ahmed Ba-Ssalamah
Journal:  Radiology       Date:  2013-10-28       Impact factor: 11.105

10.  Randomized multicentre trial of gadoxetic acid-enhanced MRI versus conventional MRI or CT in the staging of colorectal cancer liver metastases.

Authors:  C J Zech; P Korpraphong; A Huppertz; T Denecke; M J Kim; W Tanomkiat; E Jonas; A Ba-Ssalamah
Journal:  Br J Surg       Date:  2014-03-20       Impact factor: 6.939

View more
  1 in total

Review 1.  [Functional MR imaging of the liver].

Authors:  A Wibmer; R Nolz; M Trauner; A Ba-Ssalamah
Journal:  Radiologe       Date:  2015-12       Impact factor: 0.635

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.